entity

ADMA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ADMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
1Hypotheses
1Analyses
2Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (2)

TargetRelationTypeStr
PRMTsinhibitsprotein0.90
nitric oxide synthasesinhibitsprotein0.70

Incoming (1)

SourceRelationTypeStr
PRMT activitycausesprocess0.90

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Concrete Development Roadmap and Final Position 0.000 - -

Mentioning Analyses (1)

Scientific analyses that reference this entity

What is the therapeutic window between insufficient and toxic levels of TDP-43 a

neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.895

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate highlighted a critical dosing paradox where both hypo- and hypermethy

closed · Rounds: 4 · Score: 0.82 · 2026-04-12

Related Research

Hypotheses and analyses mentioning ADMA in their description or question text

No additional research found